VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 98 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,653 | +97.7% | 31,181 | +192.1% | 0.00% | – |
| Q2 2023 | $122,229 | -63.3% | 10,675 | -75.3% | 0.00% | -100.0% |
| Q1 2023 | $333,080 | +117.7% | 43,201 | +115.3% | 0.00% | 0.0% |
| Q1 2022 | $153,000 | +282.5% | 20,066 | +35.4% | 0.00% | – |
| Q4 2021 | $40,000 | -54.0% | 14,818 | -55.4% | 0.00% | – |
| Q3 2021 | $87,000 | -76.0% | 33,257 | -62.2% | 0.00% | -100.0% |
| Q2 2021 | $363,000 | +441.8% | 87,960 | +518.2% | 0.00% | – |
| Q1 2021 | $67,000 | -96.2% | 14,229 | -88.8% | 0.00% | -100.0% |
| Q4 2019 | $1,774,000 | -29.8% | 127,179 | -13.3% | 0.01% | -52.2% |
| Q3 2019 | $2,526,000 | +667.8% | 146,770 | +319.5% | 0.02% | +475.0% |
| Q4 2018 | $329,000 | +15.0% | 34,983 | +131.7% | 0.00% | +33.3% |
| Q3 2018 | $286,000 | -22.1% | 15,100 | -19.7% | 0.00% | -40.0% |
| Q2 2018 | $367,000 | +60.3% | 18,800 | +36.5% | 0.01% | +25.0% |
| Q4 2017 | $229,000 | – | 13,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |